Falsification of home rapid antigen lateral flow tests during the COVID-19 pandemic.

Publication date: Feb 09, 2024

During the COVID-19 pandemic, lateral flow tests (LFTs) were used to regulate access to work, education, social activities, and travel. However, falsification of home LFT results was a concern. Falsification of test results during an ongoing pandemic is a sensitive issue. Consequently, respondents may not answer truthfully to questions about LFT falsification behaviours (FBs) when asked directly. Indirect questioning techniques such as the Extended Crosswise model (ECWM) can provide more reliable prevalence estimates of sensitive behaviors than direct questioning. Here we report the prevalence of LFT FBs in a representative sample in England (n = 1577) using direct questioning (DQ) and the ECWM. We examine the role of demographic and psychological variables as predictors of LFT FBs. We show that the prevalence estimates of the FBs in the DQ condition were significantly lower than the ECWM estimates, e. g., reporting a negative result without conducting a test: 5. 7% DQ vs 18. 4% ECWM. Moral norms, subjective norms, anticipated regret, perception of risk to self, and trust in government predicted some of the FBs. Indirect questioning techniques can help provide more realistic and higher quality data about compliance with behavioural regulations to government and public health agencies.

Open Access PDF

Concepts Keywords
Conducting Covid
Demographic Ecwm
Dq Estimates
Pandemic Falsification
Fbs
Flow
Home
Lateral
Lft
Pandemic
Prevalence
Questioning
Sensitive
Test
Tests

Semantics

Type Source Name
disease MESH COVID-19 pandemic
disease VO report
disease IDO quality
drug DRUGBANK Coenzyme M
drug DRUGBANK Spinosad
disease VO population
disease IDO site
disease MESH infection
disease MESH education level
drug DRUGBANK Proline
disease VO Gap
disease VO vaccination
disease VO effective
disease MESH infectious diseases
disease VO company
drug DRUGBANK Methionine
drug DRUGBANK Ranitidine
disease IDO process
drug DRUGBANK Medical air
disease IDO country
disease VO efficiency
disease IDO replication
disease MESH Live births
disease VO protocol
pathway REACTOME Reproduction

Original Article

(Visited 1 times, 1 visits today)